How Supplied
NGENLA (somatrogon-ghla) injection is a clear and colorless to slightly light yellow solution containing a preservative and supplied as one single-patient-use disposable prefilled pen per carton available in the following packages:
| 24 mg/1.2 mL Prefilled Pen NDC: 0069-0505-02 | 60 mg/1.2 mL Prefilled Pen NDC: 0069-0520-02 | |
|---|---|---|
Somatrogon-ghla solution concentration | 20 mg/mL | 50 mg/mL |
Color scheme | Lilac pen cap, injection button and label | Blue pen cap, injection button and label |
Dose increments | 0.2 mg/0.01 mL | 0.5 mg/0.01 mL |
Maximum dose | 12 mg (0.6 mL) | 30 mg (0.6 mL) |
Not made with natural rubber latex.
Sterile needles are required for administration but not included. Consult the Instructions for Use for needles that can be used.
Storage and Handling
Before first use: Store refrigerated at 36°F to 46°F (2°C to 8°C) in the original carton to protect from light.
After first use: Store the pen refrigerated at 36°F to 46°F (2°C to 8°C) between each use, for up to 28 days.
Do not freeze or shake. Do not expose to heat. Do not use if it has been frozen. Store away from direct sunlight.
Always remove and safely discard the needle after each injection and store the NGENLA prefilled pen without an injection needle attached. Always use a new needle for each injection. Replace the cap on your prefilled pen when it is not in use. Write the date of first use in the space provided on the pen label. The prefilled pen should not be used more than 28 days after first use.
How Supplied
NGENLA (somatrogon-ghla) injection is a clear and colorless to slightly light yellow solution containing a preservative and supplied as one single-patient-use disposable prefilled pen per carton available in the following packages:
| 24 mg/1.2 mL Prefilled Pen NDC: 0069-0505-02 | 60 mg/1.2 mL Prefilled Pen NDC: 0069-0520-02 | |
|---|---|---|
Somatrogon-ghla solution concentration | 20 mg/mL | 50 mg/mL |
Color scheme | Lilac pen cap, injection button and label | Blue pen cap, injection button and label |
Dose increments | 0.2 mg/0.01 mL | 0.5 mg/0.01 mL |
Maximum dose | 12 mg (0.6 mL) | 30 mg (0.6 mL) |
Not made with natural rubber latex.
Sterile needles are required for administration but not included. Consult the Instructions for Use for needles that can be used.
Storage and Handling
Before first use: Store refrigerated at 36°F to 46°F (2°C to 8°C) in the original carton to protect from light.
After first use: Store the pen refrigerated at 36°F to 46°F (2°C to 8°C) between each use, for up to 28 days.
Do not freeze or shake. Do not expose to heat. Do not use if it has been frozen. Store away from direct sunlight.
Always remove and safely discard the needle after each injection and store the NGENLA prefilled pen without an injection needle attached. Always use a new needle for each injection. Replace the cap on your prefilled pen when it is not in use. Write the date of first use in the space provided on the pen label. The prefilled pen should not be used more than 28 days after first use.
{{section_body_html_patient}}
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
Pfizer Safety
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.